---
document_datetime: 2024-01-25 08:37:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kaftrio-epar-all-authorised-presentations_en.pdf
document_name: kaftrio-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9289645
conversion_datetime: 2025-12-19 14:03:51.129638
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength                | Pharmaceutical Form   | Route of Administration   | Immediate Packaging           | Pack size   |
|------------------|-------------------|-------------------------|-----------------------|---------------------------|-------------------------------|-------------|
| EU/1/20/1468/001 | Kaftrio           | 75 mg / 50 mg / 100 mg  | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC/paper/alu) | 56 tablets  |
| EU/1/20/1468/002 | Kaftrio           | 37.5 mg / 25 mg / 50 mg | Film-coated tablet    | Oral use                  | blister (PCTFE/PVC/paper/alu) | 56 tablets  |
| EU/1/20/1468/003 | Kaftrio           | 60 mg / 40 mg / 80 mg   | Granules              | Oral use                  | sachet (BOPET/PE/Foil/PE)     | 28 sachets  |
| EU/1/20/1468/004 | Kaftrio           | 75 mg / 50 mg / 100 mg  | Granules              | Oral use                  | sachet (BOPET/PE/Foil/PE)     | 28 sachets  |